Risk markers for cardiovascular disease

Details for Australian Patent Application No. 2011235920 (hide)

Owner The Cleveland Clinic Foundation

Inventors Smith, Jonathan; Zheng, Lemin; Hazen, Stanley; Zhang, Renliang; Penn, Marc S.

Agent Spruson & Ferguson

Pub. Number AU-A-2011235920

Parent 2004296829

Filing date 7 October 2011

Wipo publication date 3 November 2011

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/92 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving lipids, e.g. cholesterol

Event Publications

27 October 2011 Complete Application Filed

3 November 2011 Application Open to Public Inspection

  Published as AU-A-2011235920

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235921-Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor

2011235919-Information processing apparatus and method, information processing system, and program